Head-to-Head

Halozyme Therapeutics, Inc. vs. Moderna, Inc. Common Stock

HALO

Halozyme Therapeutics, Inc.

$95.58 -0.95%

VS MRNA

Moderna, Inc. Common Stock

$215.27 -3.63%

Moderna, Inc. Common Stock (MRNA) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

HALOMRNA
Market Cap $11.00 billion $90.38 billion

MRNA leads on 1 of 1 size & scale factors.

Risk & Sentiment

HALOMRNA
Short Interest 9.75% 0.01%

MRNA leads on 1 of 1 risk & sentiment factors.

Dig deeper: HALO overview, HALO financials, MRNA overview, MRNA financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.